Full text
PDFPage 469
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amris C. J. Inhibition of fibrinolytic and thromboplastic activity by Trasylol. Scand J Haematol. 1966;3(1):19–32. doi: 10.1111/j.1600-0609.1966.tb00622.x. [DOI] [PubMed] [Google Scholar]
- BENZER H., BLUMEL G., PIZA F. [The effects of trypsin inhibitors on blood coagulation]. Wien Med Wochenschr. 1960 Jul 16;110:609–612. [PubMed] [Google Scholar]
- Blombäck B., Blombäck M., Olsson P. Action of a proteolytic enzyme inhibitor on blood coagulation in vitro. Thromb Diath Haemorrh. 1967 Aug 15;18(1-2):190–197. [PubMed] [Google Scholar]
- Cochrane C. G., Revak S. D., Wuepper K. D. Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein. J Exp Med. 1973 Dec 1;138(6):1564–1583. doi: 10.1084/jem.138.6.1564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haberland G. L., Matis P., Pauschinger P., Thies H. A., Vinazzer H. Zur Beeinflussung postoperativer Zirkulations- und Gerinnungsveränderungen durch den Proteinaseninhibitor Trysylol. Med Welt. 1969 May 31;22:1270–1275. [PubMed] [Google Scholar]
- Nordström S., Olsson P., Blombäck M. Thromboplastin-induced hypercoagulability and its prevention. Nature. 1965 May 8;206(984):632–633. doi: 10.1038/206632b0. [DOI] [PubMed] [Google Scholar]
- Ratnoff O. D. Some recent advances in the study of hemostasis. Circ Res. 1974 Jul;35(1):1–14. doi: 10.1161/01.res.35.1.1. [DOI] [PubMed] [Google Scholar]
- Saito H., Ratnoff O. D. Inhibition of normal clotting and Fletcher factor activity by rabbit anti-kallikrein antiserum. Nature. 1974 Apr 12;248(449):597–598. doi: 10.1038/248597a0. [DOI] [PubMed] [Google Scholar]